---
aliases:
  - Breast Cancer gene 1
---
BRCA1 (Breast Cancer [[gene]] 1) is a [[gene]] that produces a protein responsible for repairing damaged DNA. This protein plays a critical role in maintaining the stability of a cellâ€™s genetic material. When BRCA1 functions properly, it helps prevent cells from growing uncontrollably, which is a key factor in the development of cancer.

### Key Points About BRCA1:

1. **Mutation and Cancer Risk**: 
   - Mutations in the BRCA1 [[gene]] can significantly increase the risk of developing certain types of cancers, particularly breast and ovarian cancer. Women with a BRCA1 mutation have a 55-65% chance of developing breast cancer by the age of 70, compared to about 12% in the general population.
   - They also have a higher risk of ovarian cancer, with a lifetime risk estimated at 39-46%.

2. **Inheritance**:
   - BRCA1 mutations are inherited in an autosomal dominant manner, meaning that if one parent carries a mutation in the BRCA1 [[gene]], there is a 50% chance of passing it on to their children, regardless of gender.
   - Both men and women can carry and pass on BRCA1 mutations, although men are less likely to develop breast cancer, they still have an increased risk compared to the general male population. They also have a higher risk of other cancers, such as prostate cancer.

3. **Testing**:
   - [[genetic testing]] for BRCA1 mutations is recommended for individuals with a strong family history of breast, ovarian, pancreatic, or prostate cancer, particularly if these cancers occurred at a young age. The test typically involves a [[Blood]] or saliva sample, which is analyzed for mutations in the BRCA1 [[gene]].

4. **Impact on Treatment**:
   - Knowing one's BRCA1 status can significantly impact treatment decisions. For example, women with BRCA1 mutations may opt for more aggressive treatment options, such as bilateral mastectomy (removal of both breasts) or prophylactic oophorectomy (removal of the ovaries) to reduce their cancer risk.
   - Additionally, some targeted therapies, like PARP inhibitors, are specifically effective in treating cancers associated with BRCA1 mutations.

5. **Prevention and Management**:
   - Individuals with BRCA1 mutations are often advised to undergo more frequent cancer screenings, such as mammograms, MRIs, and pelvic exams, starting at an earlier age.
   - Preventive measures, including lifestyle changes, medications, and prophylactic surgeries, are considered to reduce the risk of developing cancer.

Understanding one's BRCA1 status is crucial for managing cancer risk and making informed decisions about preventive measures and treatments.